The revenue in the otc pharmaceuticals market in Canada was forecast to continuously increase between 2024 and 2029 by in total 0.8 billion U.S. dollars (+21.92 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 4.45 billion U.S. dollars and therefore a new peak in 2029. Find further information concerning the average revenue per capita in the otc pharmaceuticals market in Malta and the revenue change in the 'Analgesics' segment of the otc pharmaceuticals market in Malaysia. The Statista Market Insights cover a broad range of additional markets.

The revenue in the 'Hand Sanitizer' segment of the otc pharmaceuticals market in Canada was forecast to continuously increase between 2024 and 2029 by in total 10.7 million U.S. dollars (+19.19 percent). According to this forecast, in 2029, the revenue will have increased for the sixth consecutive year to 66.47 million U.S. dollars. Find further information concerning the average revenue per capita in the 'Cold & Cough Remedies' segment of the otc pharmaceuticals market in the Philippines and the revenue change in the 'Skin Treatment' segment of the otc pharmaceuticals market in Singapore. The Statista Market Insights cover a broad range of additional markets.

The United States & Canada over-the-counter (OTC) pet nutritional supplements market size stood at US$ 1,031.4 million in 2022. The market is anticipated to cross a valuation of US$ 1,920.7 million by the end of 2033.

Attributes	Key Insights
United States & Canada OTC Pet Nutritional Supplements Market Estimated Size (2023E)	US$ 1,082.8 million
Projected Market Valuation (2033F)	US$ 1,920.7 million
Value-based CAGR (2023 to 2033)	5.9%
Collective Value Share: Top 5 Players (2022A)	30% to 35%

Country-wise Insights

Country	United States
Market Share (2023)	87.9%
Market Share (2033)	89.7%
BPS Analysis	(+) 174

Country	Canada
Market Share (2023)	12.1%
Market Share (2033)	10.3%
BPS Analysis	(-) 174

Scope of the Report

Attribute	Details
Estimated Market Size (2023)	US$ 1,082.8 million
Projected Market Valuation (2033)	US$ 1,920.7 million
Value-based CAGR (2023 to 2033)	5.9%
Forecast Period	2023 to 2033
Historical Data Available for	2018 to 2022
Market Analysis	Value (US$ million)
Key Regions Covered	North America
Key Countries Covered	United States Canada
Key Segments Covered	Product Type Pet Type Form Sales Channel Country
Key Companies Profiled	Elanco Animal Health Inc. Pet Honesty Zoetis Inc. Nutramax Laboratories Beaphar Nestle Purina Nutri- Vet NaturVet VetriScience Laboratories Zesty Paws Pet Naturals of Vermont Grizzly Pet Products Ark Naturals Others (As Per Request)
Report Coverage	Market Forecast, Company Share Analysis, Competition Intelligence, Market Dynamics and Challenges, and Strategic Growth Initiatives

The revenue in the otc pharmaceuticals e-commerce market in Canada was forecast to continuously increase between 2024 and 2029 by in total 1.1 billion U.S. dollars (+54.99 percent). After the sixth consecutive increasing year, the revenue is estimated to reach 3.2 billion U.S. dollars and therefore a new peak in 2029. Find further information concerning the revenue in the otc pharmaceuticals e-commerce market in Italy and the revenue in the otc pharmaceuticals e-commerce market in the United States. The Statista Market Insights cover a broad range of additional markets.

The over-the-counter pain medication market size to attain a valuation of by 2034, up from in 2024. The over-the-counter analgesics market is projected to evolve at a CAGR of 4.0% between 2024 and 2034.

Attributes	Details
Market Value for 2024	US$ 23,705.60 million
Market Value for 2034	US$ 35,090.10 million
Market CAGR from 2024 to 2034	4.0%

Healthcare Expenditures Cast Shadow on Over-the-counter Pain Medication Sales

Attributes	Details
Market Value for 2019	US$ 18,678.80 million
Market Value for 2023	US$ 22,741.60 million
Market CAGR from 2019 to 2023	4.0%

Category-wise Outlook

Segment	Acetaminophen
Share (2024)	46%

Segment	Oral
Share (2024)	44%

Country-wise Analysis

Countries	CAGR (2024 to 2034)
India	5.4%
Thailand	5.0%
Indonesia	3.7%
Malaysia	3.7%

Countries	CAGR (2024 to 2034)
United Kingdom	4.0%
Italy	3.8%
France	3.6%
Germany	3.4%
Spain	2.8%

Countries	CAGR (2024 to 2034)
United States	3.8%
Canada	4.5%

The average revenue per user in the otc pharmaceuticals e-commerce market in Canada was forecast to increase between 2024 and 2029 by in total 50.1 U.S. dollars (+20.64 percent). This overall increase does not happen continuously, notably not in 2029. The average revenue per user is estimated to amount to 292.77 U.S. dollars in 2029. Find further information concerning the average revenue per user in the otc pharmaceuticals e-commerce market in Austria and the revenue in the otc pharmaceuticals e-commerce market in France. The Statista Market Insights cover a broad range of additional markets.

The average revenue per capita in the 'Vitamins & Minerals' segment of the otc pharmaceuticals market in Canada was forecast to continuously increase between 2024 and 2029 by in total 5.5 U.S. dollars (+21.71 percent). After the ninth consecutive increasing year, the average revenue per capita is estimated to reach 30.87 U.S. dollars and therefore a new peak in 2029. Find further information concerning the average revenue per capita in the 'Hand Sanitizer' segment of the otc pharmaceuticals market in Taiwan and the revenue in the 'Digestives & Intestinal Remedies' segment of the otc pharmaceuticals market in Russia. The Statista Market Insights cover a broad range of additional markets.

Snapshot img

Amlodipine Besylate Market Size 2024-2028

The amlodipine besylate market size is forecast to increase by USD 196.4 million at a CAGR of 3.3% between 2023 and 2028.

The market is experiencing significant growth due to the rising incidence of hypertension, a major health concern In the US. This condition, also known as high blood pressure, affects millions of Americans and requires effective treatment to prevent complications. Amlodipine Besylate, a calcium channel blocker, plays a crucial role in managing hypertension by relaxing blood vessels and reducing heart workload. Moreover, the increasing usage of Amlodipine Besylate in various treatments, including angina pectoris and chronic stable angina, further boosts market growth. However, the potential side effects on human health, such as dizziness, headache, and swelling, may pose challenges to market expansion. Common side effects of amlodipine besylate include stomach pain, nausea, tiredness, insomnia, edema, dizziness, and flushing.
Nevertheless, continuous research and development efforts to mitigate these side effects and improve patient outcomes are expected to provide opportunities for market growth. In summary, the market is driven by the increasing prevalence of hypertension and its usage in various treatments. However, the potential side effects may pose challenges, necessitating ongoing research and development efforts to ensure patient safety and market growth.

What will be the Size of the Amlodipine Besylate Market During the Forecast Period?

Request Free Sample

The market is driven by the growing prevalence of cardiovascular diseases, such as aortic stenosis, angina, and heart attack. Amlodipine Besylate is a calcium channel blocker available in various dosage forms, including oral tablets, oral solution, and oral suspension. Its mechanism of action involves relaxing the muscles In the walls of blood vessels, improving blood flow and reducing the workload on the heart. Common side effects include stomach pain, nausea, tiredness, sleepiness, edema, dizziness, flushing, and decreased blood pressure or hypotension.
Moreover, these medications should be stored at room temperature and away from direct sunlight. Prescription Amlodipine Besylate brands, such as Norvasc and Katerzia, dominate the market, while over-the-counter (OTC) medicaments containing Amlodipine Benzoate are also available. The market is expected to grow due to the increasing demand for effective treatments for cardiovascular diseases and the expanding patient population. However, potential challenges include the development of alternatives and the risk of allergic reactions.

How is this Amlodipine Besylate Industry segmented and which is the largest segment?

The industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Application

  High blood pressure
  Heart diseases


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

By Application Insights

The high blood pressure segment is estimated to witness significant growth during the forecast period. Amlodipine Besylate is a crucial medication used to manage high blood pressure, preventing potential damage to vital organs such as the brain, heart, and kidneys. Despite feeling well, patients with hypertension are required to continue taking this medication as high blood pressure often goes unnoticed until complications arise. Amlodipine functions in preventing angina, or chest pain, which can be indicative of heart issues. This medication is typically prescribed for long-term use due to the chronic nature of hypertension. Store Amlodipine Besylate at room temperature, away from heat and moisture. Side effects may include stomach pain, nausea, tiredness, sleepiness, edema, and dizziness.

Get a glance at the Amlodipine Besylate Industry report of share of various segments Request Free Sample

The high blood pressure segment was valued at USD 728.30 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 52% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The market in North America is driven by the high prevalence of hypertension and coronary artery disease in the US and Canada. The US dominates the region due to its large market size and significant investment in pharmaceutical research and development, particularly in the cardiovascular segment. The presence of major pharmaceutica

Snapshot img

Paracetamol Market Size 2025-2029

The paracetamol market size is forecast to increase by USD 1.07 billion at a CAGR of 10% between 2024 and 2029.

Paracetamol, a widely used over-the-counter (OTC) medication, exhibits promising growth in the global market. Key factors fueling this expansion include the substantial utilization of paracetamol as an active pharmaceutical ingredient (API) in numerous OTC drugs. Paracetamol is available in various forms, such as capsules, liquids, powders, rectal, intravenous, and intravenous paracetamol. Additionally, there is a rising preference for extended-release formulations due to their enhanced efficacy and patient compliance. However, concerns over the potential adverse effects of analgesics, particularly liver toxicity, pose a significant challenge to market growth. Manufacturers need to address these concerns through rigorous safety testing and innovative formulations to ensure consumer safety and trust. In summary, the market is driven by its extensive use in OTC drugs and the increasing demand for extended-release formulations, while facing challenges due to safety concerns.

What will be the Size of the Paracetamol Market During the Forecast Period?

Request Free Sample

Paracetamol, also known as acetaminophen, is a widely used pain reliever and antipyretic in the healthcare industry. The drug's popularity can be attributed to its effectiveness in managing various types of pain, including migraines, chronic daily headaches, and chronic pain in the elderly. In France, the Reliance Program ensures the availability and accessibility of essential medicines, including paracetamol, to the population. The regulatory authority oversees the production, distribution, and use of paracetamol and other pain management drugs.



Paracetamol's versatility extends to the treatment of conditions like the flu, menstrual periods, toothaches, backaches, and osteoarthritis. Its antipyretic properties make it an effective fever reducer. The drug's long-term use, particularly in the elderly, raises concerns regarding its potential impact on longevity. The Migraine Trust highlights the importance of effective pain management for individuals suffering from chronic conditions like migraines. Paracetamol, when used appropriately, can provide relief for these patients. However, it is essential to consider the potential side effects and interactions with other medications before use. Intravenous paracetamol is an alternative administration route for patients who cannot take the drug orally. This form of paracetamol is particularly useful in hospitals and healthcare settings where patients require immediate pain relief. In conclusion, paracetamol remains a crucial pain management drug in the healthcare industry, with applications ranging from common ailments to chronic conditions. Regulatory authorities play a vital role in ensuring its safe and effective use, while ongoing research explores new ways to optimize its benefits and minimize potential risks.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Application

  Surgical
  Non-surgical


Formulation

  Powder
  Granules


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    India
    Japan


  Rest of World (ROW)

By Application Insights

The surgical segment is estimated to witness significant growth during the forecast period.

Paracetamol, a commonly used over-the-counter analgesic and antipyretic, finds extensive application in managing various health conditions. In the medical sphere, it is particularly effective in alleviating backaches, osteoarthritis pain, and fever. For instance, it is often prescribed for individuals suffering from migraines, a condition managed by the Migraine Trust.

Additionally, paracetamol is beneficial for patients with diabetes, epilepsy, asthma, and oral diseases, including toothache. In surgical settings, paracetamol is administered intravenously or orally for postoperative pain management. Its usage in the perioperative period reduces the requirement for opioids, thereby mitigating the risks associated with their use. Paracetamol's widespread utility and effectiveness make it an indispensable component in healthcare.

Get a glance at the market report of share of various segments Request Free Sample

The surgical segment was valued at USD 671.60 million in 2019 and showed a gradual increase during the forecast period.

Regional Analysis

Asia is estimated to contribute 39% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the r

The revenue in the 'Vitamins & Minerals' segment of the otc pharmaceuticals market in Canada was forecast to continuously increase between 2024 and 2029 by in total 266 million U.S. dollars (+26.86 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 1.3 billion U.S. dollars and therefore a new peak in 2029. Find further information concerning the revenue change in the 'Cold & Cough Remedies' segment of the otc pharmaceuticals market in Singapore and the revenue in the 'Vitamins & Minerals' segment of the otc pharmaceuticals market in Japan. The Statista Market Insights cover a broad range of additional markets.

Snapshot img

Consumer Healthcare Market Size 2025-2029

The consumer healthcare market size is forecast to increase by USD 189.8 billion at a CAGR of 7.1% between 2024 and 2029.

The market is experiencing significant growth, driven by increasing awareness about lifestyle diseases and the accelerated use of online resources. According to recent studies, non-communicable diseases such as diabetes, cardiovascular diseases, and cancer are on the rise, leading consumers to seek proactive healthcare solutions. The market is responding to this trend with an expanding range of products and services, including dietary supplements, over-the-counter medicines, and digital health solutions. However, the market is not without challenges. One major issue is the lack of corroborative studies on the efficacy and safety of dietary supplements, leading to regulatory scrutiny and consumer skepticism. Digital health innovations, such as telemedicine, health apps, and wearables, offer convenience and accessibility to consumers. Additionally, the digitalization of healthcare presents opportunities but also brings challenges such as data privacy concerns and the need for standardization. Companies seeking to capitalize on market opportunities and navigate these challenges effectively must prioritize transparency, evidence-based innovation, and regulatory compliance. By staying abreast of these trends and addressing consumer needs, they can position themselves for long-term success in the dynamic market.

What will be the Size of the Consumer Healthcare Market during the forecast period?

Request Free Sample

The market encompasses a broad range of products and services designed to meet the healthcare needs of individuals outside of traditional medical settings. Key categories include wellness, oral health, nutrition, skin health, medicines, healthcare professional engagement, personal healthcare products, health supplements, cosmetics, disinfectants, consumer medical devices, nutraceuticals, digital health, OTC goods, preventative medicine, and drug distribution. This market is characterized by strong growth, driven by increasing consumer awareness and demand for self-care solutions. Trends include the rise of personalized and digital health offerings, the integration of healthcare professionals into consumer product offerings, and the increasing importance of preventative medicine.
Counterfeit drugs and safety concerns remain challenges, while the growing popularity of OTC medicines and weight loss products adds to the market's complexity. Overall, the market is a dynamic and evolving landscape, presenting both opportunities and challenges for stakeholders.

How is this Consumer Healthcare Industry segmented?

The consumer healthcare industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  OTC pharmaceuticals
  Dietary supplements


Distribution Channel

  Offline
  Online


Geography

  North America

    US
    Canada


  Asia
  Europe

    France
    Germany
    UK


  Rest of World (ROW)

By Product Insights

The OTC pharmaceuticals segment is estimated to witness significant growth during the forecast period. Over-the-counter (OTC) drugs, also known as self-medications, are non-prescription medicines approved by regulatory bodies like the US Food and Drug Administration (FDA) for individual purchase and use. These medications cater to various health concerns, encompassing pain relief, skin conditions, respiratory symptoms, sleep disorders, smoking cessation, weight management, and gastrointestinal issues. OTC drugs are accessible through multiple channels, including pharmacies, grocery stores, and online retail pharmacies. These products are readily available on the shelves, catering to consumers' convenience and accessibility. OTC drugs encompass a wide range of therapeutic areas, including analgesics, weight loss products, gastrointestinal products, skin products, mineral supplements, vitamin supplements, sleeping aids, ophthalmic products, sports nutrition, sports supplements, vitamins, minerals, amino acids, probiotics, omega-3 fatty acids, carbohydrates, and botanicals.

Get a glance at the market report of share of various segments Request Free Sample

The OTC pharmaceuticals segment was valued at USD 252.00 billion in 2019 and showed a gradual increase during the forecast period.

Regional Analysis

Asia is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market size of various regions, Request Free Sample

The North American region leads the market, account

The average revenue per capita in the otc pharmaceuticals market in Taiwan was forecast to continuously increase between 2024 and 2029 by in total 28.8 U.S. dollars (+33.13 percent). After the sixth consecutive increasing year, the average revenue per capita is estimated to reach 115.7 U.S. dollars and therefore a new peak in 2029. Find further information concerning the revenue in the otc pharmaceuticals market in Cuba and the revenue in the 'Vitamins & Minerals' segment of the otc pharmaceuticals market in Canada. The Statista Market Insights cover a broad range of additional markets.

Prescription drugs: ePharmacies offer a wide range of prescription drugs for chronic conditions, such as diabetes, hypertension, and heart disease.Over-the-counter (OTC) medications: They provide convenient access to common OTC medications, such as pain relievers, allergy medications, and vitamins.Other healthcare products: ePharmacies also offer a variety of healthcare products, including medical devices, diagnostic tools, and personal care items. Recent developments include: September 2022: Amazon planned to sell prescription drugs online in Japan. She aims to work with small and medium-sized pharmacies to build a platform where patients can be instructed online on how to take their medication. Customers can have their medicines delivered to their homes without going to the pharmacy., September 2022: Walmart Canada partnered with Canada Health Infoway. Infoway's PrescribeIT e-prescription service is currently available at 14 Walmart Canada pharmacies in Alberta, Ontario, New Brunswick, and Saskatchewan, with planned to expand to other locations by the year’s end., January 2019: Zur Rose Group has completed the acquisition of the e-commerce business of medpex, Germany's third-largest online pharmacy. In this way, the Zur Rose Group significantly increased its market share in Germany., February 2022: Medicure Inc. has launched a domestic consumer e-commerce pharmacy platform through its US subsidiary, Marley Drug Pharmacy. This will allow Americans to buy FDA-approved medicines at bargain prices on Marley Drugs' new e-commerce site, with home delivery to all 50 states... Key drivers for this market are: RISING ADOPTION RATE OF INTERNET AND HEALTHCARE APPS 27, RISING OCCURRENCE OF CHRONIC AND INFECTIOUS DISEASES 27; INCREASING GERIARTIC POPULATION 27. Potential restraints include: COUNTERFEIT MEDICINES 28.

Snapshot img

Lice Treatment Market Size 2024-2028

The lice treatment market size is forecast to increase by USD 117.3 million at a CAGR of 5.8% between 2023 and 2028.

The market is experiencing significant growth due to the rising prevalence of lice infestations among children and adults, as well as the increasing population of school-going children. This trend is driven by the need for effective and eco-friendly lice treatment products, as lice infestations can spread quickly in childcare facilities, schools, and other communal settings. Topical treatments remain the most common form of lice treatment, with many consumers opting for over-the-counter (OTC) products. However, concerns over the efficacy and safety of these products have led to a growing demand for natural and organic alternatives. Moreover, the presence of lice in mammals, such as pets, has also contributed to the market's expansion. In response, manufacturers are developing innovative solutions, including lice prevention products like shampoos, conditioners, and combs, as well as hats and other accessories designed to minimize the risk of infestations. The high cost of healthcare and the desire for affordable personal items further fuel the market's growth. Overall, the market is expected to continue its expansion in the coming years, driven by these key trends and challenges.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market encompasses a range of products and services designed to address lice infestations, affecting both children and adults. This market is driven by the growing awareness of lice infestations, the need for effective and convenient treatment options, and the increasing preference for non-toxic and natural remedies. The primary focus of the market is to provide solutions for managing and eliminating lice infestations. Topical treatments, such as shampoos and lotions, remain popular due to their ease of use and quick results. Oral treatments are also available for more severe cases. Over-the-counter (OTC) lice treatments offer convenience and affordability for consumers, making them a preferred choice for many. However, prescription lice treatments may be necessary for persistent infestations or those resistant to OTC treatments. Prevention is a crucial aspect of the market. Natural lice remedies, such as essential oils and vinegar, are gaining popularity as effective and safe alternatives to chemical-based treatments.
Lice prevention tips, such as avoiding head-to-head contact and regularly checking for lice, are essential for reducing the risk of infestations. Innovations in the market include enzyme-based and silicone-based treatments, which offer longer-lasting results and fewer side effects than traditional chemical treatments. Online lice treatment services and home lice removal kits are also gaining traction, providing consumers with more accessible and convenient options. Lice infestations are common in schools and daycare centers, leading to increased awareness and the need for effective lice treatment and prevention solutions. This market also faces challenges, such as the development of lice strains resistant to certain treatments and the potential for misdiagnosis or under-reporting of infestations.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Distribution Channel

  Hospitals and clinics
  Online
  Retail pharmacies


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Distribution Channel Insights

The hospitals and clinics segment is estimated to witness significant growth during the forecast period.

The prevalence of head lice infestations continues to rise, fueling the expansion of the market. This growth can be attributed to the increasing research and development investments in creating more effective non-toxic lice treatment formulations. Additionally, the trend towards health-conscious consumers seeking natural remedies for various health issues is driving demand for non-toxic lice treatments. However, the availability and affordability of these treatments may hinder growth in underdeveloped and developing countries, where people often do not consider lice infestations to be a serious medical concern. Pricing analysis and expert evaluation of side effects and regulatory frameworks are essential for market participants to remain competitive. Silicone-based treatments have gained popularity due to their ease of application and effectiveness, but their long-term safety is a concern. Overall, the market is expe

The average revenue per capita in the otc pharmaceuticals market in Hong Kong was forecast to continuously increase between 2024 and 2029 by in total 56.2 U.S. dollars (+34.03 percent). After the seventh consecutive increasing year, the average revenue per capita is estimated to reach 221.31 U.S. dollars and therefore a new peak in 2029. Find further information concerning the average revenue per capita in the 'Vitamins & Minerals' segment of the otc pharmaceuticals market in Canada and the average revenue per capita in the 'Digestives & Intestinal Remedies' segment of the otc pharmaceuticals market in the Philippines. The Statista Market Insights cover a broad range of additional markets.

Snapshot img

EPharmacy Market Size 2025-2029

The EPharmacy market size is forecast to increase by USD 148.5 billion at a CAGR of 21.2% between 2024 and 2029.

The market is witnessing significant growth due to several key trends. The availability of advanced robotic pharmacy prescription dispensing systems and pharmacy automation systems is driving market growth. Artificial intelligence and medical devices are being integrated into these systems to enhance accuracy and efficiency. Additionally, the increasing popularity of e-commerce and the convenience it offers to consumers are fueling market expansion. The integration of digital health technologies is further improving the delivery of healthcare services, making it easier for consumers to manage their health remotely. However, challenges such as the growing acceptance of EPharmacy services in newly regulated European states and the risk of illegal and counterfeit trading of drugs through EPharmacy platforms remain major concerns. The rise of health and wellness trends is also contributing to the demand for more accessible, convenient, and personalized healthcare solutions. Overall, the market is expected to continue its growth trajectory, driven by technological advancements, changing consumer preferences, and an increasing focus on health and wellness.

What will be the Size of the EPharmacy Market During the Forecast Period?

Request Free Sample

The market, encompassing mail-order medicines and over-the-counter products sold through e-commerce channels, continues to experience significant growth as more patients turn to the convenience of online purchasing for their healthcare needs. With an increasing number of chronically ill patients and elderly citizens seeking easier access to prescription medicines and healthcare products, market sales have been on an upward trajectory. Tech-savvy consumers, including millennials, are driving the demand for digitalization in healthcare services, leading to the emergence of startups leveraging information technologies, algorithms, and artificial intelligence to enhance customer satisfaction. The integration of telemedicine adoption, virtual healthcare services, remote patient monitoring, and patient engagement platforms further underscores the digital health trends shaping the market.
Regulations governing online pharmacies and healthcare data security remain critical concerns for market participants. The pharmaceuticals industry continues to innovate, with advancements in healthcare technology and the increasing popularity of virtual healthcare services. Online pharmacy marketing and digital health investment are key areas of focus for market players.

How is this EPharmacy Industry segmented and which is the largest segment?

The EPharmacy industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product Type

  Medications
  Health and wellness and nutrition
  Personal care and essentials


Drug Class

  Prescription drugs
  Over-the-counter drugs


Distribution Channel

  Mobile applications
  Online platforms


End-user

  Individuals
  Commercial


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  APAC

    China
    India
    Japan
    South Korea


  South America



  Middle East and Africa

By Product Type Insights

The medications segment is estimated to witness significant growth during the forecast period.

In the modern healthcare landscape, EPharmacy, which encompasses mail-order medicines, e-commerce, and online pharmacies, plays a significant role in delivering prescription medicines and over-the-counter products to patients. This sector caters to the needs of various demographics, including chronically ill patients, elderly citizens, and millennials, through the digitalization of healthcare services. The convenience offered by online platforms, such as doctor consultations, smartphone orders, and doorstep delivery, appeals to tech-savvy consumers. However, regulations are stringent to combat illegitimate online pharmacies and ensure the safety of counterfeit, adulterated, or incorrectly labeled medications. EPharmacy solutions have become vital services, especially during lockdowns and urban center living, where operational costs and infrastructure priorities align with healthcare goals.

The sector includes independent internet-only outlets, electronic subsidiaries of retail pharmacy stores, and delivery companies. Platforms offering online shopping, diagnostics, and prescribed medications have become essential for consumer shopping habits, particularly for those requiring chronic care or living in developing economies. The industry continues to evolve with advancements in

Snapshot img

Menstrual Drugs Market Size 2024-2028

The menstrual drugs market size is forecast to increase by USD 3.62 billion at a CAGR of 7.75% between 2023 and 2028. The market is experiencing significant growth due to several key factors. Firstly, there is a growing awareness and emphasis on menstrual hygiene and overall women's health, leading to an increase in demand for menstrual cramp treatments. Secondly, drug therapy, particularly prostaglandins, non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen sodium, remain popular options for managing menstrual cramps. Additionally, hormonal therapy is also gaining traction as an alternative treatment. As Menstrual Hygiene Day continues to raise awareness about menstrual health, the market for menstrual drugs is expected to continue its expansion. Lastly, non-drug alternatives, including herbal remedies and menstrual cups, are gaining popularity as more women seek natural and eco-friendly options. Overall, the market is poised for continued growth as more women seek effective solutions for managing menstrual cramps and maintaining their overall health.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market encompasses various treatments for menstrual cramps and related conditions such as primary dysmenorrhea and secondary dysmenorrhea. These conditions, characterized by pelvic pain and discomfort during menstruation, can significantly impact a woman's quality of life. The treatment market for menstrual cramps consists of several types, including medication, therapy, and surgery. Medications are the most common form of treatment and can be administered orally, topically, or injectable. Prostaglandins, a type of hormone-like substance, are often used to treat primary dysmenorrhea. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen sodium are popular over-the-counter options for relieving menstrual cramps.

Furthermore, hormonal therapy is another treatment type for menstrual cramps, particularly for those with secondary dysmenorrhea or endometriosis. This therapy aims to regulate hormonal imbalances and reduce pelvic pain. Clinical trials for new hormonal therapies are currently in phase 2, indicating ongoing research and development in this area. Diagnosis of menstrual cramps and related conditions involves various methods, including ultrasound, laparoscopy, and CT scan. These diagnostic tools help healthcare professionals identify the underlying causes of pelvic pain and determine the most effective treatment approach. The duration of menstrual cramp treatment varies depending on the individual's response to therapy and the severity of their symptoms.

For some, over-the-counter medications may be sufficient, while others may require prescription medications or even surgery. In terms of administration, medications for menstrual cramps can be taken orally, applied topically, or administered via injection. Oral administration is the most common method, as it allows for easy and convenient dosing. Topical administration, such as heating pads or hot water bottles, can also provide relief for some women. The market is expected to grow due to increasing awareness of menstrual health and the availability of effective treatment options. Additionally, advancements in diagnostic tools and treatment methods are driving innovation in the market.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Hormonal treatments
  Pain relief medications
  PMS and PMDD medications
  Menstrual regulation drugs
  Endometriosis treatments


Route Of Administration

  Oral medications
  Injectables
  Topical applications


Geography

  North America

    US


  Europe

    Germany
    UK


  Asia

    China
    India


  Rest of World (ROW)

By Type Insights

The hormonal treatments segment is estimated to witness significant growth during the forecast period. The hormonal treatments segment in the market caters to various menstrual conditions by addressing hormonal imbalances and regulating menstrual cycles. This segment comprises a multitude of pharmaceutical interventions, such as hormonal contraceptives, hormone replacement therapies, and other hormonal medications. The rising incidence of menstrual disorders and the escalating demand for efficient hormonal management solutions have amplified the importance of the hormonal treatments segment in The market. One of the primary factors fueling the expansion of the hormonal treatments segment is the extensive application of hormonal contraceptives for birth control and menstrual cycle regulation. These treatments are administered through various modes, including

The number of users in the otc pharmaceuticals e-commerce market in Egypt was forecast to continuously increase between 2024 and 2029 by in total 3.3 million users (+55.93 percent). After the tenth consecutive increasing year, the number of users is estimated to reach 9.21 million users and therefore a new peak in 2029. Notably, the number of users of the otc pharmaceuticals e-commerce market was continuously increasing over the past years.Find further information concerning the average revenue per user in the otc pharmaceuticals e-commerce market in Canada and the revenue in the otc pharmaceuticals e-commerce market in Japan. The Statista Market Insights cover a broad range of additional markets.

Snapshot img

Musculoskeletal Drugs Market Size 2024-2028

The musculoskeletal drugs market size is forecast to increase by USD 26.37 billion at a CAGR of 5.8% between 2023 and 2028.

The market is experiencing significant growth due to several key factors. One of the primary drivers is the increasing geriatric population, as older adults are more susceptible to musculoskeletal disorders (MSDs). Another trend influencing market growth is the adoption of artificial intelligence (AI) and machine learning (ML) technologies for diagnosing MSDs, enabling early intervention and improved patient outcomes. However, high treatment costs associated with MSDs remain a challenge, necessitating the development of cost-effective treatment options and payment models. These factors, among others, are shaping the growth trajectory of the market.

What will be the Size of the Musculoskeletal Drugs Market During the Forecast Period?

Request Free Sample

The market is experiencing significant growth due to the rising prevalence of muscle-related symptoms, including spasticity, spasms, and musculoskeletal pain. Prescription medications, such as antispastics, antispasmodics, skeletal muscle relaxants, and smooth muscle relaxants, are in high demand to manage these conditions. The market is driven by increasing healthcare expenditures, an aging population, and a growing awareness of the importance of self-care.
Moreover, over-the-counter (OTC) options, like acetaminophen, also contribute to the market's growth. Companies are focusing on developing innovative solutions to address unmet needs, such as improved patient compliance and access to translated information. Additionally, financial support, helplines, and community initiatives, including home recipes, newsletters, and webinars, are essential resources for patients and caregivers. Organizations like MHA Kids and Workwise provide valuable resources, while bequests and donations support research and development efforts.

How is this Musculoskeletal Drugs Industry segmented and which is the largest segment?

The musculoskeletal drugs industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Drug Class

  Nonsteroidal anti inflammatory drugs
  Disease modifying anti rheumatic drugs
  Analgesics
  Corticosteroids
  Others


Distribution Channel

  Hospital pharmacy
  Retail pharmacy
  Online pharmacy


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France


  Asia

    China
    India
    Japan


  Rest of World (ROW)

By Drug Class Insights

The nonsteroidal anti inflammatory drugs segment is estimated to witness significant growth during the forecast period.

Non-steroidal anti-inflammatory drugs (NSAIDs) are essential in managing musculoskeletal conditions by inhibiting prostaglandin production, which mediates pain and inflammation. NSAIDs are widely used for treating various musculoskeletal disorders, including joint inflammation, muscle disorders, and autoimmune-mediated and connective tissue disorders. These conditions affect individuals with cerebral palsy, multiple sclerosis, aging populations, and others. NSAIDs come in various forms, such as over-the-counter and prescription medications, catering to diverse patient needs. Common NSAIDs include ibuprofen, naproxen, diclofenac, and celecoxib, each with distinct dosing regimens and durations of action. Healthcare providers utilize these options to customize treatment plans based on individual patient requirements.

Get a glance at the Musculoskeletal Drugs Industry report of share of various segments Request Free Sample

The nonsteroidal anti inflammatory drugs segment was valued at USD 19.18 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 32% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American region holds a substantial share In the market due to the high prevalence of musculoskeletal disorders (MSDs) and considerable healthcare expenditures. According to the Bureau of Labor Statistics (BLS), there were 976,090 cases of MSDs reported In the private sector In the US in 2021, leading to 502,380 days-away-from-work (DAFW) cases. In Canada, there were 10,211 lost-time injuries caused by MSDs in 2022, marking a 2.5% increase from the previous year. The increasing obesity rate and aging population in North America further contribute to the rising incidence of MSDs. In 2023, every US state and territory report

The global sore throat lozenges market is estimated to be valued at US$ 4.4 billion in 2024. The market is expected to expand at a CAGR rate of 5.6% and reach a valuation of ~US$ 7.5 billion by 2034.

Data Points	Market Insights
Sore Throat Lozenges Market Value, 2023	US$ 4.1 billion
Estimated Market Value 2024	US$ 4.4 billion
Projected Market Value 2034	US$ 7.5 billion
Valued-based CAGR (2024 to 2034)	5.6%
Market Share of Top 5 Countries	57.1%

Sales Analysis of Sore Throat Lozenges During Historical Period Vs. Market Outlook

Attribute	Details
HCAGR (2019 to 2023)	4.9%

Country-wise Insights

Country/Region	CAGR (2024 to 2034)
United Kingdom	5.4%
Germany	5.2%
Japan	4.6%
China	6.6%

Category-wise Insights

Top Product Type	Hard Candy Lozenges
Market Share in 2024	46.5%

Top Type	OTC Medication
Market Share in 2024	85.3%

Top Distribution Channel	Retail Pharmacies
Market Share in 2024	36.7%

Report Scope as per Sore Throat Lozenges Industry Analysis

Attribute	Details
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2033
Market Analysis	US$ billion for Value
Key Regions Covered	North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, Russia, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, Israel, North Africa, and South Africa
Key Market Segments Covered	Product, Type, Distribution Channel, and Region
Key Companies Profiled	iNova Pharmaceuticals Procter & Gamble (P&G) Company Reckitt Benckiser Group Plc Ricola AG Mondel?z International. Thornton & Ross Ltd. Traditional Medicinals, Inc. Bliss GVS Pharma Ltd. GlaxoSmithKline Plc Honibe SSL International Cipla Ltd Novartis Johnson & Johnson
Pricing	Available upon Request